BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28892161)

  • 1. A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors.
    Agathangelidis A; Xochelli A; Stamatopoulos K
    J Pathol; 2017 Dec; 243(4):403-406. PubMed ID: 28892161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.
    Moody S; Escudero-Ibarz L; Wang M; Clipson A; Ochoa Ruiz E; Dunn-Walters D; Xue X; Zeng N; Robson A; Chuang SS; Cogliatti S; Liu H; Goodlad J; Ashton-Key M; Raderer M; Bi Y; Du MQ
    J Pathol; 2017 Sep; 243(1):3-8. PubMed ID: 28682481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
    Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
    Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations.
    Xochelli A; Bikos V; Polychronidou E; Galigalidou C; Agathangelidis A; Charlotte F; Moschonas P; Davis Z; Colombo M; Roumelioti M; Sutton LA; Groenen P; van den Brand M; Boudjoghra M; Algara P; Traverse-Glehen A; Ferrer A; Stalika E; Karypidou M; Kanellis G; Kalpadakis C; Mollejo M; Pangalis G; Vlamos P; Amini RM; Pospisilova S; Gonzalez D; Ponzoni M; Anagnostopoulos A; Giudicelli V; Lefranc MP; Espinet B; Panagiotidis P; Piris MA; Du MQ; Rosenquist R; Papadaki T; Belessi C; Ferrarini M; Oscier D; Tzovaras D; Ghia P; Davi F; Hadzidimitriou A; Stamatopoulos K
    J Pathol; 2019 Apr; 247(4):416-421. PubMed ID: 30484876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
    Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
    Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
    Xochelli A; Baliakas P; Kavakiotis I; Agathangelidis A; Sutton LA; Minga E; Ntoufa S; Tausch E; Yan XJ; Shanafelt T; Plevova K; Boudjogra M; Rossi D; Davis Z; Navarro A; Sandberg Y; Vojdeman FJ; Scarfo L; Stavroyianni N; Sudarikov A; Veronese S; Tzenou T; Karan-Djurasevic T; Catherwood M; Kienle D; Chatzouli M; Facco M; Bahlo J; Pott C; Pedersen LB; Mansouri L; Smedby KE; Chu CC; Giudicelli V; Lefranc MP; Panagiotidis P; Juliusson G; Anagnostopoulos A; Vlahavas I; Antic D; Trentin L; Montillo M; Niemann C; Döhner H; Langerak AW; Pospisilova S; Hallek M; Campo E; Chiorazzi N; Maglaveras N; Oscier D; Gaidano G; Jelinek DF; Stilgenbauer S; Chouvarda I; Darzentas N; Belessi C; Davi F; Hadzidimitriou A; Rosenquist R; Ghia P; Stamatopoulos K
    Clin Cancer Res; 2017 Sep; 23(17):5292-5301. PubMed ID: 28536306
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
    Kostareli E; Hadzidimitriou A; Stavroyianni N; Darzentas N; Athanasiadou A; Gounari M; Bikos V; Agathagelidis A; Touloumenidou T; Zorbas I; Kouvatsi A; Laoutaris N; Fassas A; Anagnostopoulos A; Belessi C; Stamatopoulos K
    Leukemia; 2009 May; 23(5):919-24. PubMed ID: 19148139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
    Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
    Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
    Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
    Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
    Sutton LA; Young E; Baliakas P; Hadzidimitriou A; Moysiadis T; Plevova K; Rossi D; Kminkova J; Stalika E; Pedersen LB; Malcikova J; Agathangelidis A; Davis Z; Mansouri L; Scarfò L; Boudjoghra M; Navarro A; Muggen AF; Yan XJ; Nguyen-Khac F; Larrayoz M; Panagiotidis P; Chiorazzi N; Niemann CU; Belessi C; Campo E; Strefford JC; Langerak AW; Oscier D; Gaidano G; Pospisilova S; Davi F; Ghia P; Stamatopoulos K; Rosenquist R;
    Haematologica; 2016 Aug; 101(8):959-67. PubMed ID: 27198719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic hypermutation and B-cell lymphoma.
    Dunn-Walters D; Thiede C; Alpen B; Spencer J
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases.
    Biderman BV; Likold EB; Smirnova SY; Nikitin EA; Koroleva DA; Zvonkov EE; Al-Radi LS; Julhakyan HL; Sudarikov AB
    Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e938-e945. PubMed ID: 34384734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
    Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution.
    Kostareli E; Sutton LA; Hadzidimitriou A; Darzentas N; Kouvatsi A; Tsaftaris A; Anagnostopoulos A; Rosenquist R; Stamatopoulos K
    Leukemia; 2010 Jul; 24(7):1317-24. PubMed ID: 20463750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa.
    Bahler DW; Szankasi P; Kulkarni S; Tubbs RR; Cook JR; Swerdlow SH
    Mod Pathol; 2009 Jun; 22(6):833-8. PubMed ID: 19347017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications.
    Vardi A; Agathangelidis A; Sutton LA; Chatzouli M; Scarfò L; Mansouri L; Douka V; Anagnostopoulos A; Darzentas N; Rosenquist R; Ghia P; Belessi C; Stamatopoulos K
    Clin Cancer Res; 2014 Jan; 20(2):323-30. PubMed ID: 24240110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa.
    Coupland SE; Foss HD; Anagnostopoulos I; Hummel M; Stein H
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):555-62. PubMed ID: 10067957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.